Press Releases
Hogan Lovells announces new management changes to IPMT practice and Germany
07 December 2022
PartnerDusseldorf
Email [email protected]hoganlovells.com
Phone +49 211 13 68 328
LanguagesEnglish, German
Practice groupIntellectual Property, Media, and Technology
Clients especially like Miriam Gundt's pragmatic and solution-orientated approach. Miriam is well connected in our global network. She is an ideal "go-to" lawyer for the coordination of international patent disputes and the enforcement of intellectual property rights in various European jurisdictions. Her strategic advice comprises questions regarding the new Unified Patent Court (UPC) and the European Patent with Unitary Effect. She represents and advises national and international clients in all matters of intellectual property and technical industrial property rights, with a focus on patents and utility models. Her experience comprises both patent litigation and contractual IP matters, including licence agreements and R&D Agreements.
Further, she possesses outstanding knowledge in the area of Supplementary Protection Certificates (SPCs). Miriam focuses on the pharma and biotech industry, life science and medical engineering. Miriam is highly skilled in the area of interim legal protection, including preliminary injunctions and evidence seizures. She has successfully obtained and enforced preliminary injunctions for various clients.
Miriam is a member of various associations in the field of intellectual property (GRUR, EPLAW, AIPLA, VPP) and regularly speaks at national and international conferences and seminars on patent law related topics. Miriam is very committed to diversity & inclusion and has been appointed as Head of Diversity & Inclusion in Europe at the beginning of 2018.
Included for Intellectual Property law
Edition Best Lawyers™ in Germany
Recommended lawyer for Patent Litigation
WirtschaftsWoche, Ausgabe 10/2019
Recommended lawyer for Patent Litigation: Dispute Settlement
Legal 500 Germany
Industry Focus: Healthcare and Life Sciences, Next Generation
Legal 500 EMEA
Nominated for Rising Star IP
Euromoney European Women in Business Law Awards
Education
University of Aberdeen
University of Milan
Osnabrück University
Memberships
EPLAW
AIPLA
VPP
GRUR
Women in IP
Managing international patent litigation for major pharmaceutical company on its blockbuster product, including infringement proceedings in Germany, Japan, and EPO opposition proceedings.
Advising a major pharmaceutical/biotech company on a multi-jurisdictional defense strategy regarding patent litigation in the field of stem cells for use in treatment of chronic inflammatory diseases.
Representing a leading medical device company in patent infringement proceedings including recovering damages.
Winning the first compulsory licence case that was ever granted in interim proceedings at the German Federal Patent Court on Merck's HIV/AIDS medicament Isentress®.
Press Releases
07 December 2022
Awards and Rankings
11 October 2022
Insights and Analysis
Registered Content
26 July 2022
Webinar
10 March 2022 | 3:00 PM - 4:30 PM (JST)
News
19 May 2020
Insights and Analysis
Registered Content
21 April 2020